Managed Account Advisors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Managed Account Advisors’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$5.13M	Buy	44,521 +7,263	+19%	+$763K	﹤0.01%	1413
2015 Q1	$3.56M	Buy	37,258 +6,447	+21%	+$482K	﹤0.01%	1585
2014 Q4	$2.07M	Buy	30,811 +3,756	+14%	+$233K	﹤0.01%	1802
2014 Q3	$1.46M	Buy	+27,055	New	+$1.33M	﹤0.01%	1922

Other funds holding CBPO

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Managed Account Advisors's CBPO Position: Q2 2015 in Review

Managed Account Advisors increased its China Biologic Products Holdings, Inc. (CBPO) stake by 19% in Q2 2015, buying an estimated $763K and bringing the position to 44,521 shares worth $5.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1413.

Managed Account Advisors first reported a position in CBPO in Q3 2014 and has held it in 4 quarters since. 109 funds tracked by Wall St. Rank hold CBPO as of Q2 2015.

Managed Account Advisors held 44,521 shares of China Biologic Products Holdings, Inc. worth $5.13M as of Q2 2015.
Managed Account Advisors bought 7,263 China Biologic Products Holdings, Inc. shares in Q2 2015, an estimated $763K.
China Biologic Products Holdings, Inc. made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #1413 holding.
Managed Account Advisors first reported a position in China Biologic Products Holdings, Inc. in Q3 2014 and has held it in 4 quarters since.
109 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.